Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787176 · ClinicalTrials.gov registry record · NA
The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 251
- Enrollment target
NCT00787176: Clinical Trial NA study, sponsored by Northwestern University.
NCT00787176 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 251 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00787176, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 251 participants
- Enrollment target
Study Summary
Fetal heart rate patterns are an important parameter in the diagnosis of non-reassuring fetal status. Combined-spinal epidural analgesia is a method of initiating labor analgesia used by approximately 90% of the parturients at Prentice Women's Hospital. Optimizing the variables which could affect fetal heart rate patterns at the time of initiation of analgesia, such as fluid administration and oxytocin management, could help us provide better care for our patients and their fetuses. Hypotheses: The combination of fluid administration and lower doses of oxytocin administration will have fewer adverse fetal heart rate changes in the first 60 minutes following initiation of labor analgesia.
Primary Outcome
The number of participants who experience non-reassuring fetal heart rate tracings obtained via electronic recording during the first 30 minutes after the placement of epidural analgesia
Interventions
- DRUG Group A Intravenous bolus of 1000 ml lactated ringers solution
- DRUG Group B Intravenous bolus bolus 1000 ml lactated ringers solution oxytocin decrease to 1/2 current rate
- DRUG Group C 125 mL/hr of lactated ringers
- DRUG Group D 125 mL/hr lactated ringers oxytocin decreased to 1/2 current rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-07 |
| Phase | NA |
Why NCT00787176 stopped before completion
NCT00787176 is an interventional study that assigns participants to a tested intervention. The registered 251 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 4 interventions - of which Group A Intravenous bolus of 1000 ml lactated ringers solution is the first listed.
NCT00787176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00787176 about?
NCT00787176 is a clinical study titled "The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes". Fetal heart rate patterns are an important parameter in the diagnosis of non-reassuring fetal status. Combined-spinal epidural analgesia is a method of initiating labor analgesia used by approximately 90% of the parturients at Prentice Women's Hospital. Optimizing the variables which could affect fe...
What is the current status of trial NCT00787176?
This trial is currently terminated. It is a NA study. The enrollment target is 251 participants. The study started on 2007-09. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00787176?
The interventions under investigation include: Group A Intravenous bolus of 1000 ml lactated ringers solution (DRUG), Group B Intravenous bolus bolus 1000 ml lactated ringers solution oxytocin decrease to 1/2 current rate (DRUG), Group C 125 mL/hr of lactated ringers (DRUG), Group D 125 mL/hr lactated ringers oxytocin decreased to 1/2 current rate (DRUG).
Who is sponsoring clinical trial NCT00787176?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00787176's enrollment target sits among peer trials
251 410th of 2000 higher than 1,591 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06043817 · 251 participants · Phase 1
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia